Zdrowie i gospodarka · 10/08/2026

FDA Clears OZOBAX (Baclofen) Oral Solution for Continued Sale

The US Food and Drug Administration (FDA) has ruled that OZOBAX (baclofen) oral solution, 5mg/5mL, was not withdrawn from sale due to safety or efficacy concerns, allowing it to remain on the market and paving the way for future abbreviated new drug applications (ANDAs).